Abstract
To compare the different methods of pain control intervention during fixed orthodontic appliance therapy.
A computerized literature search was performed in MEDLINE (1966–2009), The Cochrane Library (Issue 4, 2009), EMBASE (1984–2009), and CNKI (1994–2009) to collect randomized controlled trials (RCTs) for pain reduction during orthodontic treatment. Data were independently extracted by two reviewers and a quality assessment was carried out. The Cochrane Collaboration's RevMan5 software was used for data analysis. The Cochrane Oral Health Group's statistical guidelines were followed.
Twenty-six RCTs were identified and six trials including 388 subjects were included. Meta-analysis showed that ibuprofen had a pain control effect at 6 hours and at 24 hours after archwire placement compared with the placebo group. The standard mean difference was −0.47 and −0.48, respectively. There was no difference in pain control between ibuprofen, acetaminophen, and aspirin. Other analgesics such as tenoxicam and valdecoxib had relatively lower visual analog scale (VAS) scores in pain perception. Low-level laser therapy (LLLT) was also an effective approach for pain relief with VAS scores of 3.30 in the LLLT group and 7.25 in the control group.
Analgesics are still the main treatment modality to reduce orthodontic pain despite their side effects. Some long-acting nonsteroidal anti-inflammatory drugs (NSAIDs) and cyclo-oxygenase enzyme (COX-2) inhibitors are recommended for their comparatively lesser side effects. Their preemptive use is promising. Other approaches such as LLLT have aroused researchers' attention.
INTRODUCTION
Pain and discomfort are common clinical symptoms in orthodontic patients, especially 2 to 4 days after fixed orthodontic appliances are placed. It has even been suggested that orthodontic pain can discourage some patients from seeking treatment and might cause a number of patients to discontinue treatment.1 After an orthodontic procedure, it is typical to experience pain and soreness 24 hours after placement of the appliance. The pain generally occurs after placement of the first archwire2–4 and subsides after a week.5
Researchers attributed the initial and delayed pain response to hyperalgesia of the periodontal ligament. This hyperalgesia makes the periodontal ligament sensitive to released algogens such as histamine, bradykinin, prostaglandins, and serotonin.6 The increase in the levels of these mediators elicits a pain response following orthodontic force application.
At present there is no universal recommendation on the use of analgesics in pain reduction. Nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen and acetaminophen are commonly recommended. Their analgesic action has been explained by their ability to inhibit the synthesis of prostaglandins at the site of the tissue injury. This is thought to be through inhibition of the cyclo-oxygenase enzymes COX-1 and COX-2.7
Because the use of analgesics has side effects, they are contraindicated in patients who are allergic to those drugs. To find alternatives for pain relief, researchers have looked for other new, but safer approaches, such as low-level laser therapy (LLLT).8–12 LLLT is a new internationally accepted designation and is defined as laser treatment in which the energy output is low enough so as not to cause a rise in the temperature of the treated tissue above 36.5°C or normal body temperature.13 Because of its lower energy output and intensity, its effects are mainly nonthermal and biostimulatory. The mechanism of laser analgesia is its anti-inflammatory and regenerative effects on neurons and its conditioning effect on tooth enamel.14,15
Since the measurements of pain intensity are diverse, most of the studies have utilized a visual analog scale (VAS), which is designed to present the subject with a rating scale with minimum constraints16 to evaluate pain perception. The VAS is a line whose ends are anchored and measures the pain intensity by a gradated scale from 0 to 10. The subject is expected to mark a location on the line corresponding to the amount of pain experienced, considering 0 as no pain and 10 as unbearable pain intensity. The distance of the mark from the end of the scale is then taken to represent a “pain score.” Most subjects with pain understand the concept and can quickly make the measurement.
At present, there are some animal models established to evaluate pain relief and tooth movement through animal behavior.17,18 These procedures followed the Guidelines of Animal Research or were approved by the institutional review board of the universities. However, these studies have limited clinical significance, are inconsistent and less pertinent than clinical studies, and offer results that can only be extrapolated to the human with great caution. Researchers tend to design more reasonable ethical human intervention experiments and to seek a relatively more efficient way to control orthodontic pain. Among these studies, randomized clinical trials (RCTs) and systematic reviews with meta-analysis are believed to be the better way to provide more practical and reliable suggestions and information for clinical practice.19,20
The purpose of this systematic review is to compare the clinical outcome of different methods of pain intervention. Two questions are put forward: (1) Are medications still the main treatment modality to reduce orthodontic pain? (2) Are there any other new approaches proved to be more effective in pain control?
MATERIALS AND METHODS
Literature Search and Study Selection
A computerized literature search was performed using MEDLINE (1966–2009) (Table 1), The Cochrane Library (Issue 4, 2009), EMBASE (1984–2009), and CNKI (1994–2009) with no language restriction. Randomized controlled trials and controlled clinical trials conducted in humans were identified. A number of useful references and appropriate search strategies were received from the Cochrane Handbook for Systematic Reviews of Interventions.21 Two reviewers independently conducted the study selection using pilot-tested forms22 (Table 1). Titles and abstracts of all potential relevant studies were identified before retrieval of the full articles. Full articles were obtained if there was insufficient data in the title and abstract to make a clear decision.
Selection Criteria
The inclusion and exclusion criteria are listed in Table 2. Two reviewers independently evaluated the quality of the searched articles to establish whether the studies met the inclusion criteria. Disagreements were resolved by discussion, and a third reviewer consulted where necessary. The articles in their reference lists were also scanned to be optimally identified. All studies meeting the inclusion criteria underwent validity assessment and data extraction. Studies rejected at this or subsequent stages were recorded in Figure 1, which describes the review retrieval flow from selection to meta-analysis.
Methodologic Quality
According to the principles and procedures of a meta-analysis,23 two reviewers independently assessed each selected study for methodologic quality, based on the criteria defined by Jadad et al.24, maximum score 5 and high/acceptable score ≥3 (Table 3). All of the included studies should have “acceptable” methodologic quality.
Data Extraction and Meta-analysis
Data were extracted from each study independently and entered into a computerized database. The information extracted included the name of the first author, year of publication, mean scores of experimental and control groups, and standard deviation of experimental and control groups. Differences were resolved by discussion to reach consensus between the reviewers.
Meta-analysis was conducted with the help of RevMan 5 software provided by the Cochrane Collaboration. Standard mean difference and 95% confidence interval (CI) were calculated using continuous data of the selected studies. Statistical tests of heterogeneity were used to assess whether the observed variability in study results was greater than that expected to occur by chance. The heterogeneity between studies was assessed using a Q statistical test by examining the type of participants, interventions, and outcomes in each study. Meta-analyses were done only if there were studies of similar comparisons reporting the same outcome measures.25,26
RESULTS
Study Selection and Data Summary
Characteristics of the trials
Of the eight qualified trials (Ngan et al.27, Polat and Karaman28, Polat' et al.29, Young et al.30, Turhani et al.10, Salmassian et al.31, Arantes et al.32, Tortamano et al.11), one trial (Polat et al.29) was excluded due to data duplication with authors' other trial (Polat and Karaman28) and another (Turhani et al.10) was judged not to be a double-blinded RCT with its Jadad Scale at 2.
Six eligible trials (Ngan et al.27, Polat and Karaman28, Young et al.30, Salmassian et al.31, Arantes et al.32, Tortamano et al.11), comprising 388 subjects, met the inclusion criteria. All trials were conducted at university dental clinics and all trials declared that patients had signed the necessary consent informs. The data summary of these eight trials and their Jadad Scale are presented in Table 4.
Data analysis
Medicine
Ibuprofen vs control groups: meta-analysis
Ibuprofen was used as a representative NSAIDs on the basis of its efficacy for postoperative relief of dental pain. Acetaminophen was believed not to affect tooth movement, and aspirin was the traditional NSAID. The question of whether ibuprofen had an advantage in pain relief compared to acetaminophen and aspirin needs to be further studied. Totally, three trials were included in this group. According to different control groups and inactive group, the meta-analysis was divided into three subgroups: (1) ibuprofen vs acetaminophen (Polat and Karaman28 and Salmassian et al.31); (2) ibuprofen vs aspirin (Ngan et al.27 and Polat and Karaman28; (3) ibuprofen vs placebo (Ngan et al.27, Polat and Karaman28 and Salmassian et al.31). Meta-analyses of these three subgroups are summarized in Tables 5–7.
In subgroup 1, at different time points within 7 days, the standard mean difference ranged between 0.20 and 0.41, indicating the results slightly favored the control group (acetaminophen). Though acetaminophen appeared to have a better effect on pain relief than ibuprofen, this difference did not reach statistical significance with an overall P > .05. In subgroup 2, similar results appeared between ibuprofen and aspirin.
In subgroup 3, compared with the placebo, ibuprofen was indicated to be more effective for pain relief at 6 hours and at 24 hours when the initial archwire was placed. The standard mean differences were −0.47 and −0.48 at 6 hours and 24 hours, respectively, and the overall P values were all .01 (P < .05), showing that the results favored the experimental group (ibuprofen) more than the control group (placebo). However, after 24 hours, the standard mean difference still favored the ibuprofen group, but its effects had no statistically significant difference with the placebo (P > .05) (Figure 2).
Ibuprofen (experimental) and placebo (control) groups for meta-analysis results, reported in standard mean difference (95% confidence interval), show evidence favoring ibuprofen for pain reduction at 6 hours and at 24 hours after activation of fixed orthodontic treatment.
Ibuprofen (experimental) and placebo (control) groups for meta-analysis results, reported in standard mean difference (95% confidence interval), show evidence favoring ibuprofen for pain reduction at 6 hours and at 24 hours after activation of fixed orthodontic treatment.
Valdecoxib
One RCT was obtained. Young et al.30 reported that the scores of VAS were 4.6, 6.6, 8.8, respectively, when measuring experienced discomfort in preemptive, postoperative, and placebo use. This suggests that preemptive analgesics might be an approach to prevent discomfort associated with initial archwire placement in healthy adults.
Tenoxicam
One RCT was obtained. Arantes et al.32 reported that pain intensity in the tenoxicam group was lower than in the placebo groups. The difference in pain intensity between the experimental and control groups was greatest at 12 hours when assessed after activation of orthodontic treatment.
Low-level Laser Therapy
One trial was included for this group, and there was some evidence to support the use of LLLT for pain reduction during fixed orthodontic appliance therapy. However, many diverse opinions existed concerning this kind of clinical trial, such as duration of treatment, dosage (radiant power, frequency, energy density), and pain measure, which caused us to preclude a meta-analysis.
In a study by Tortamano et al.,11 the patients in the LLLT group had less oral pain and a lower intensity of pain. The VAS score for the most painful day was 3.30 in the LLLT group compared with 7.25 in the control group with no laser treatment, and 8.55 in the placebo group with simulated laser treatment. Meanwhile, pain ceased on the third day in the LLLT group, but on the fifth day in the control and placebo groups. This indicated the efficacy of LLLT for pain control after placement of the first orthodontic archwire.
DISCUSSION
For treatment of pain induced by fixed orthodontic appliance, this systematic review found evidence favoring medicine and low-level laser therapy for pain relief in the short term.
Few in vivo studies were found in the literature search since pain is a subjective phenomenon that is difficult to assess. Many variables come into play when one attempts to measure and quantify it.33–35 It is dependent upon factors such as age, gender, individual pain threshold, the magnitude of the force applied, present emotional state and stress, cultural differences, and previous pain experiences.34 However, as clinical trials, especially well-designed randomized clinical trials, provide more useful information and practical suggestions, it is imperative to offer an update on the interventions of pain during fixed orthodontic appliance therapy, especially after initial archwire placement.
Of six included trials, three reported using an orthodontic appliance, including edgewise, Begg, and straight-wire technique. All of these appliances are considered conventional appliances compared with the self-ligating bracket systems. It is believed these appliances result in similar pain experience, and therefore their data are synthesized in this meta-analysis.
Since gastric ulceration, bleeding disorders, allergy, etc are among the common adverse effects in NSAIDs, orthodontic researchers and clinicians have devoted themselves to finding much safer analgesics from the many kinds of NSAIDs. At first, ibuprofen was chosen to be safe and effective. But clinical trials revealed that the effect of ibuprofen on pain relief was limited.
Also, there are still many controversies on the use of NSAIDs because of their potential influence on tooth movement.36,37 Acetaminophen is preferred because it does not inhibit prostaglandin synthesis and has no deleterious effects on tooth movement.38–40 Meta-analysis has revealed that there is no difference in pain relief between ibuprofen, acetaminophen, and aspirin. Although compared with a placebo, ibuprofen has a better effect on pain control and there always exists the placebo effect. This calls for properly performed double-blind trials to avoid this psychological effect. Recently, some long-acting NSAIDs such as tenoxicam and COX-2 inhibitors such as valdecoxib were studied, and they have proved to be more effective and convenient than other analgesics. Recent research towards their preemptive use as well as concentration on the ideal dosage of those agents is promising.
Considering the side effects of analgesics, other approaches have been tested to reduce pain from orthodontic procedures. Data have shown the efficacy of LLLT for pain control after placement of the first archwire.10,11 LLLT for pain relief is believed to be noninvasive and easy to administer, with no known adverse tissue reactions. The reason for reducing its clinical use would be the total time (32–37.5 minutes) for application to both dental arches. Also, LLLT should be applied immediately after orthodontic appliance bonding in clinics.11 A well-designed double-blind trial is another limitation. How could the laser therapy be handled between the experimental and control groups so that the operators and patients are both blinded to the difference? Face mask or glasses are suggested by researchers in the included studies, but whether these approaches can be properly performed to eliminate experimental bias needs further investigation.
Apart from medication and LLLT, many researchers have been exploring other effective ways for pain management during fixed orthodontic treatment. The use of vibratory stimulation to reduce orthodontic pain was first reported by Marie et al.,41 but on detailed analysis it was found that once the discomfort sets in, most of the patients were not able to tolerate the vibrations. Bartlett et al.42 compared pretreatment and follow-up calls and the effects of each on pain perception after initial archwire placement and found that a telephone call can reduce patients' self-reported pain. Chewing gum or a plastic wafer was also suggested. Hwang et al.43 observed pain relief in the majority of patients after chewing wafers (56%), but the rest of the subjects reported increased discomfort.
However, all of these suggested pain management methods were devoid of well-designed RCTs, and therefore were excluded from this systematic review. Because of the limited amount of comparative evidence, there is an apparent need for high-quality RCTs to further investigate the effectiveness of these methods for interventions during fixed orthodontic appliance therapy. Orthodontic researchers and clinicians need to explore more effective treatment techniques, combinations, or approaches to evaluate and manage orthodontic pain experienced by patients.
CONCLUSIONS
Analgesics are still the main treatment modality to reduce orthodontic pain. However, the pharmacologic actions as well as their side effects should be identified before prescribing these medications in routine clinical practice.
Some long-acting NSAIDs and COX-2 inhibitors are interestingly recommended for their comparatively fewer side effects, and their preemptive use is promising.
Other relatively safer approaches such as LLLT have aroused researchers' attention. Up to now, there is still limited evidence to suggest their benefit in the use of LLLT, vibratory stimulation, and other nonpharmacologic modalities.
Acknowledgments
We acknowledge Professor SHI Zong-dao for his guidance in conducting this systematic review and meta-analysis.
REFERENCES
Author notes
PhD student, State Key Laboratory of Oral Disease and Department of Orthodontics, West China School of Dentistry, Sichuan University, Chengdu, China
PhD student, State Key Laboratory of Oral Disease and Department of Endodontics, West China School of Dentistry, Sichuan University, Chengdu, China
Professor, State Key Laboratory of Oral Disease and Department of Orthodontics, West China School of Dentistry, Sichuan University, Chengdu, China